Why Is UiPath (PATH) Stock Down -12.13% Today?
Key Takeaways
- UiPath shares plunged approximately 12.13% in Wednesday's trading session, dropping from a prior close of $12.04 to $10.58, marking one of the stock's steepest single-day declines of the year.
- A broad sell-off in AI and technology stocks served as the primary catalyst, with the Nasdaq Composite under pressure and heavyweight AI-linked names sliding in tandem.
- Persistent concerns about growth deceleration and the disruptive threat that agentic AI poses to UiPath's core robotic process automation (RPA) business continue to weigh heavily on investor sentiment.
- Elevated short interest — above 30% of the public float — likely amplified the downward move as bearish positioning intensified the selling momentum.
- Broader market caution around enterprise software spending and a string of recent analyst price-target cuts added to the negative backdrop, leaving the stock vulnerable to sharp corrections.
Opening Summary
PATH, the stock of UiPath Inc. — a New York-based enterprise automation and robotic process automation (RPA) software provider — suffered a severe sell-off on Wednesday, tumbling roughly 12.13% to $10.58 from a prior session close of $12.04. The decline erased weeks of incremental recovery and pushed the shares back toward levels not seen since early July. The rout unfolded alongside a broader downturn in AI-related equities, but UiPath's outsized losses reflected company-specific vulnerabilities that have dogged the stock throughout 2026.
Broad AI and Tech Route Sparks Heavy Selling
The most immediate trigger for Wednesday's plunge was a sector-wide decline in AI and technology stocks. The Nasdaq Composite opened in the red, while the S&P 500 also edged lower. AI-focused names including NOW (ServiceNow), ARM (Arm Holdings), KLAC (KLA Corporation), and MU (Micron Technology) all traded sharply lower at the open. UiPath, however, bore the brunt of the selling, with its decline far outpacing peers — a reflection of the market's diminished tolerance for risk in software names where the growth narrative remains under scrutiny.
Persistent AI Disruption Fears Weigh on Sentiment
Beyond the day's macro-driven pressure, UiPath continues to grapple with an existential question hanging over its business model: can the company thrive in a world where agentic AI threatens to bypass traditional RPA altogether? The rapid proliferation of large language models and autonomous AI agents has raised fears that enterprises may eventually automate workflows without needing an intermediary platform like UiPath. While the company has aggressively repositioned itself — launching agentic AI capabilities, the Maestro orchestration platform, and UiPath for Coding Agents — investors remain unconvinced that these initiatives will translate into sufficiently accelerated revenue growth. First-quarter fiscal 2027 revenue rose a respectable 17% to $418 million, and the company achieved its first GAAP-profitable quarter. Yet annual recurring revenue (ARR) grew at a slower 12% clip, and management's forward guidance implied only modest top-line acceleration, leaving the growth-reacceleration thesis unfulfilled.
Analyst Caution and Heavy Short Interest Amplify the Decline
Wall Street's posture toward PATH has grown increasingly cautious. Over the past two months, UBS, BMO Capital, Morgan Stanley, and DA Davidson have all trimmed their price targets, with several settling in the $12 to $13 range — barely above where the stock traded prior to Wednesday's rout. The consensus rating among 20 analysts sits at Hold. Compounding the bearish technical setup is an unusually high short interest: more than 32% of UiPath's public float was sold short as of mid-June, making the stock highly susceptible to outsized moves on any negative news flow or sector-wide rotation. Wednesday's decline bore the hallmarks of a momentum-driven unwind rather than a reaction to a single discrete catalyst.
Market Context and Trading Activity
Wednesday's plunge came on the heels of already elevated trading volumes. In the prior session, more than 177 million shares changed hands — roughly 235% above the three-month average — signaling heightened investor attention even before the magnitude of today's decline became clear. The stock had recently staged a partial recovery from its 52-week low of $9.20, climbing back above $12, but the breakout lacked conviction. The latest sell-off pushed PATH decisively below its 50-day moving average and toward the lower end of its recent trading range. While the broader application-software peer group also struggled — with APPN (Appian) and PEGA (Pegasystems) each nursing declines earlier in the week — UiPath's losses were disproportionately severe, underscoring the stock's fragility in risk-off conditions.
Trending AI Robots
In volatile market environments like the one affecting UiPath today, traders increasingly turn to data-driven tools to navigate rapidly shifting conditions. Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that have demonstrated the strongest performance under current market dynamics. With hundreds of bots covering thousands of tickers, spanning strategies from swing trading to long-term trend following, only those with proven real-time results earn a place in this featured lineup. Each bot specifies its strategy, timeframe, and tracked symbols, offering traders a transparent view of what is working right now. Explore the Trending AI Robots page to see which automated strategies are navigating today's market with the highest conviction.
What Comes Next for PATH
The immediate focus for PATH shareholders now shifts to the company's next earnings report, expected around September 3, 2026. Analysts are projecting fiscal second-quarter revenue of approximately $397.6 million and earnings per share of $0.15 — flat compared to the year-ago period. The critical metric will be ARR growth: management guided for second-quarter ARR of roughly $1.93 billion, and any shortfall would likely reinforce the bear thesis that UiPath's core subscription engine is losing momentum. Broader macro considerations, including enterprise IT budget scrutiny and the trajectory of interest rates, will also play an outsized role. On the competitive front, investors will monitor whether UiPath's newer agentic AI offerings — including Maestro Case and the recently announced integration for coding agents — begin converting pilot programs into scaled enterprise deployments. Until then, the stock is likely to remain range-bound and reactive to shifts in sector sentiment.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
PATH in upward trend: price rose above 50-day moving average on July 27, 2026
PATH moved above its 50-day moving average on July 27, 2026 date and that indicates a change from a downward trend to an upward trend. In of 46 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on July 28, 2026. You may want to consider a long position or call options on PATH as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PATH just turned positive on July 29, 2026. Looking at past instances where PATH's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PATH advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 157 cases where PATH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PATH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
PATH broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PATH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.541) is normal, around the industry mean (25.165). P/E Ratio (27.800) is within average values for comparable stocks, (75.319). Projected Growth (PEG Ratio) (0.600) is also within normal values, averaging (1.967). PATH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (5.382) is also within normal values, averaging (135.032).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PATH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ComputerCommunications
Advertisement